The total return over the past 12 months is +156.35% vs. +16.94% for the S&P 500. So far it's up +62.37% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +156.35% | +81.30% | +16.95% | N/A | N/A | N/A |
| Total Return CAGR | +156.35% | +81.30% | +16.95% | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Edgewise Therapeutics, Inc. (EWTX)
| Year | Start price | End price | EWTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $24.82 | $40.30 | +62.37% | +14.51% | +47.86% |
| 2025 | $26.70 | $24.82 | (7.04%) | +17.72% | (24.76%) |
| 2024 | $10.94 | $26.70 | +144.06% | +24.89% | +119.17% |
| 2023 | $8.94 | $10.94 | +22.37% | +26.19% | (3.82%) |
| 2022 | $15.28 | $8.94 | (41.49%) | (18.17%) | (23.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
